MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus
- PMID: 22842073
- PMCID: PMC3437747
- DOI: 10.1016/j.neuropharm.2012.07.026
MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus
Abstract
The neurochemical effects of MDMA (3,4-methylenedioxymethamphetamine) on monoaminergic and cholinergic systems in the rat brain have been well documented. However, little is known regarding the effects of MDMA on glutamatergic systems in the brain. In the present study the effects of multiple injections of MDMA on extracellular concentrations of glutamate in the striatum, prefrontal cortex, and dorsal hippocampus were examined. Two or four, but not one, injections of MDMA (10 mg/kg, i.p. at 2 h intervals) resulted in a 2-3 fold increase in the extracellular concentration of glutamate in the hippocampus; no increase was evident in the striatum or prefrontal cortex. Reverse dialysis of MDMA (100 μM) into the hippocampus also elicited an increase in extracellular glutamate. Treatment with the 5-HT reuptake inhibitor fluoxetine prevented the increase in extracellular glutamate in the hippocampus following the systemic administration of MDMA, as did treatment with the serotonin 5-HT2A/C receptor antagonist ketanserin. Moreover, reverse dialysis of the sodium channel blocker tetrodotoxin did not prevent the increase in extracellular glutamate in the hippocampus. These data support the view that stimulation of 5-HT2A/2C receptors on non-neuronal cells by 5-HT released by MDMA promotes glutamate efflux in the hippocampus.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures






Similar articles
-
MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.J Neuroimmune Pharmacol. 2013 Mar;8(1):58-65. doi: 10.1007/s11481-012-9420-x. Epub 2012 Nov 18. J Neuroimmune Pharmacol. 2013. PMID: 23179355 Free PMC article.
-
3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.Psychopharmacology (Berl). 2006 Jan;184(2):182-9. doi: 10.1007/s00213-005-0271-5. Epub 2005 Dec 24. Psychopharmacology (Berl). 2006. PMID: 16378215
-
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.Neuropsychopharmacology. 1997 Sep;17(3):117-29. doi: 10.1016/S0893-133X(97)00026-2. Neuropsychopharmacology. 1997. PMID: 9272479
-
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. doi: 10.1016/j.pbb.2007.10.003. Epub 2007 Oct 16. Pharmacol Biochem Behav. 2008. PMID: 18035407 Free PMC article. Review.
-
The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.Prog Neurobiol. 1996 Aug;49(5):455-79. doi: 10.1016/0301-0082(96)00027-5. Prog Neurobiol. 1996. PMID: 8895996 Review.
Cited by
-
MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors.Eur J Pharmacol. 2015 Aug 15;761:95-100. doi: 10.1016/j.ejphar.2015.04.035. Epub 2015 Apr 30. Eur J Pharmacol. 2015. PMID: 25936514 Free PMC article.
-
Crosstalk Among Disrupted Glutamatergic and Cholinergic Homeostasis and Inflammatory Response in Mechanisms Elicited by Proline in Astrocytes.Mol Neurobiol. 2016 Mar;53(2):1065-1079. doi: 10.1007/s12035-014-9067-0. Epub 2015 Jan 13. Mol Neurobiol. 2016. PMID: 25579384
-
Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells.PLoS One. 2016 Nov 18;11(11):e0166750. doi: 10.1371/journal.pone.0166750. eCollection 2016. PLoS One. 2016. PMID: 27861613 Free PMC article.
-
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24. Life Sci. 2014. PMID: 23892199 Free PMC article. Review.
-
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders.Int J Mol Sci. 2024 Jun 13;25(12):6521. doi: 10.3390/ijms25126521. Int J Mol Sci. 2024. PMID: 38928227 Free PMC article. Review.
References
-
- Adori C, Ando RD, Balazsa T, Soti C, Vas S, Palkovits M, Kovacs GG, Bagdy G. Low ambient temperature reveals distinct mechanisms for MDMA-induced serotonergic toxicity and astroglial Hsp27 heat shock response in rat brain. Neurochemistry International. 2011;59:695–705. - PubMed
-
- Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 1990;255:843–857. - PubMed
-
- Capela JP, Ruscher K, Lautenschlager M, Freyer D, Dirnagl U, Gaio AR, Bastos ML, Meisel A, Carvalho F. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience. 2006;139:1069–1081. - PubMed
-
- Cornea-Hebert V, Riad M, Wu C, Singh SK, Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. The Journal of Comparative Neurology. 1999;409:187–209. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical